Translumina augments its leadership team with two key hires

Appoints Robert Ratini as Chief Commercial Officer for Translumina’s international business, based in Switzerland, Paritosh Arora as Chief Commercial Officer for the company’s India operations, based in New Delhi, India

Translumina has augmented its leadership team with two key hires. Robert Ratini has been named as Chief Commercial Officer for Translumina’s international business, based in Switzerland and Paritosh Arora as Chief Commercial Officer for the company’s India operations, based in New Delhi, India.

Arora has over two decades of experience in the medical device industry across intervention cardiology, ENT, medical aesthetics and ophthalmology. He was previously Managing Director of Widex, a global leader in hearing aids, where he had full P&L responsibility for India, building a sizeable commercial team and dealer network that resulted in substantial growth of the business over the past five years. Prior to this, Arora led the coronary business for Medtronic in India / South Asia where he propelled the company’s performance through strong key opinion leader development and dealer management initiatives.

Ratini joins Translumina with over two decades of experience in intervention cardiology at senior leadership level. In his previous role as Vice President, Sales & Market Development at Celanova BioSciences, he led the ex-US launch of the company’s flagship COBRA stent and coordinated sales and marketing efforts across Europe, Asia, Middle-East and Latin America through direct and distribution channels. Prior to this, Ratini led global marketing and EMEA sales for Biosensors, resulting in significant market share gains for the company across international markets and also served as General Manager France and Business Director for Southern Europe for Abbott Vascular.

“We are delighted to welcome exemplary professionals such as Robert and Paritosh into the Translumina family. Their presence will bolster the senior leadership and help Translumina achieve its ambitious growth objectives both in India as well as in international markets, which already account for a significant portion of our revenues today.” said Gurmit Singh Chugh, Founder & Chairman, Translumina.

Arjun Oberoi, Managing Director, Everstone Group said “Translumina is extremely well positioned to enter its next phase of growth and the commercial leadership that Robert and Paritosh will certainly bring a lot of value to the team in helping assimilate a broader product portfolio and build robust go-to-market strategies in key geographies”.

cardiovascular medical devicesintervention cardiologyminimally invasive surgeryParitosh AroraRobert RatiniTranslumina
Comments (0)
Add Comment